Journal Article

IV.5.8 Immunosuppressive therapy

in Nephrology Dialysis Transplantation

Published on behalf of European Renal Association - European Dialysis and Transplant Assoc

Volume 17, issue suppl_4, pages 30-31
Published in print April 2002 | ISSN: 0931-0509
Published online April 2002 | e-ISSN: 1460-2385 | DOI: http://dx.doi.org/10.1093/ndt/17.suppl_4.30
IV.5.8 Immunosuppressive therapy

Show Summary Details

Preview

Guideline

A. Immunosuppressive therapies, especially corticosteroids and anticalcineurin inhibitors; contribute to the prevalence of cardiovascular risk factors, such as arterial hypertension, hyperlipidaemia and hyperglycaemia, and this effect is dose dependent. Reduction of the dose, withdrawal and/or switching to another drug could be useful to control these risk factors.

(Evidence level A)

Journal Article.  0 words. 

Subjects: Nephrology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.